Galectin Therapeutics (GALT) Minority Interest (2010 - 2016)

Galectin Therapeutics' Minority Interest history runs 5 years deep, the most recent figure standing at $1.7 million for Q3 2016.

• In Q3 2016, Minority Interest changed N/A year-over-year to $1.7 million; the TTM figure through Sep 2016 stood at $1.7 million (changed N/A YoY), while the FY2015 annual figure was $1.7 million, changed N/A from the prior year.
• Minority Interest was $1.7 million for Q3 2016 at Galectin Therapeutics, down from $3.6 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $3.6 million in Q2 2016 to a low of $1.7 million in Q4 2015.
• Historically, Minority Interest has averaged $2.2 million across 3 years, with a median of $1.7 million in 2015.